Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized Chronic Care for Smokers - Cessation Trial
NCT04188873Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Dec 2020
- Primary completion
- May 2025
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline, nicotine patch in nicotine dependence, sponsored by University of Wisconsin–Madison. Started Dec 2020; status: completed.
02
Drugs
vareniclinenicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT04188873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04188873.